// App-Quantinova.ai

5542 : ASTX660, a non-peptidomimetic antagonist of cIAP1/2 and XIAP, enhances immune mediated tumor killing and induction of immunogenic cell death

Researchers

Presenter

  • Nicola Ferrari

Principal Investigators

  • George Ward

  • Joanne Munck

  • Simone Jueliger

  • Matthew Davis

  • Christina Gewinner

  • Roberta Ferraldeschi

  • John Lyons

  • Martin John Sims

Medical Centers

  • Astex Pharmaceutical, Inc., Cambridge, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • X-linked inhibitor of apoptosis

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT02503423

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved